U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Medical Devices
  3. Products and Medical Procedures
  4. In Vitro Diagnostics
  5. Letter to Precision Quality DNA Concerning Direct to Consumer Advertising
  1. In Vitro Diagnostics

Letter to Precision Quality DNA Concerning Direct to Consumer Advertising

May 11, 2011

Andre Gous
Chief Executive Officer
Precision Quality DNA
131 Industrial Way
Fallon, NV 89406

Dear Mr. Gous:

It has come to our attention that you are currently marketing the Precision Quality DNA, a genetic testing service, intended to help individuals understand the analysis of their DNA sequence while focusing on main target genes, such as BRCA1/BRCA2, to determine that individual’s main risk factors or likely response to a particular drug.

The Precision Quality DNA appears to meet the definition of a device as that term is defined in section 201(h) of the Federal Food Drug and Cosmetic Act.

We have conducted a review of our files, and have been unable to identify any Food and Drug Administration (FDA) clearance or approval number for the Precision Quality DNA . We request that you provide us with the FDA clearance or approval number for the Precision Quality DNA . If you do not believe that you are required to obtain FDA clearance or approval for the Precision Quality DNA, please provide us with the basis for that determination.

We would like to meet with you to discuss whether the service you are promoting requires review by FDA and what information you would need to submit in order for your product to be legally marketed. Please let us know your availability and we will schedule a meeting with you. Please direct your questions and response to:

James L. Woods
Deputy Director, Patient Safety and Product Quality
Office of In Vitro Diagnostic Device Evaluation and Safety
10903 New Hampshire Avenue
White Oak 66
Silver Spring, MD 20993

We would appreciate a response within 15 days from the date of this letter. If you have any questions relating to this matter, please feel free to call Cecily Jones at 301-796-6172, or access our web site at http://www.fda.gov for general information relating to FDA's device requirements.

Sincerely yours,

James Woods
Deputy Director
Patient Safety and Product Quality
Office of In Vitro Diagnostic Device Evaluation and Safety
Center for Devices and Radiological Health

Back to Top